Tonix Pharmaceuticals Holding Corp. Uncategorized Contracts & Agreements

30 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrants Securities
Tonix Pharmaceuticals Holding Corp.
2024
Form of Securities Purchase Agreement
Tonix Pharmaceuticals Holding Corp.
2024
Form of Warrant Amendment Agreement
Tonix Pharmaceuticals Holding Corp.
2024
Form of Series E Warrant
Tonix Pharmaceuticals Holding Corp.
2024
Form of Pre-Funded Warrant
Tonix Pharmaceuticals Holding Corp.
2024
Placement Agent Agreement, dated March 28, 2024, between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners
Tonix Pharmaceuticals Holding Corp.
2024
Placement Agent Agreement, dated December 20, 2023, between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners
Tonix Pharmaceuticals Holding Corp.
2023
Description of Registrants Securities
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2023
Form of Side Letter between Tonix Pharmaceuticals Holding Corp. and each investor, dated October 25, 2022
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NV
2022
Description of Registrants Securities
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2022
Description of Registrants Securities
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2021
Form of Investor Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2021
Description of Registrants Securities
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2020
TONIXPHARMACEUTICALS HOLDING CORP. $15,000,000 COMMONSTOCK SALESAGREEMENT
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2016
TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2014
TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2014
TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 February 11, 2014
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2014
TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2013
TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2013
TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2013
TONIX PHARMACEUTICALS HOLDING CORP.
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2012
Improved Oral Delivery of Cyclobenzaprine– Feasibility Proposal
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2012
FEASIBILITY AND OPTION AGREEMENT
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2012
FEASIBILITY AND OPTION AGREEMENT
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2012
SUBSCRIPTIONAGREEMENT
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2012
Exhibit 10.20 is filed herewith as a PDF reference.
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2011
Silicon ValleySan AntonioNew YorkTorontoLondonParisFrankfurtTokyoChennai
Tonix Pharmaceuticals Holding Corp.
Biotechnology
2011
FEASIBILITY AND OPTION AGREEMENT
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2011
FINANCIAL PUBLIC RELATIONS LETTER OF AGREEMENT FOR TONIX Pharmaceuticals, Inc.
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2011
BACKGROUND
Tonix Pharmaceuticals Holding Corp.
Biotechnology
NY
2011